The clinical data on the primary RCCs were not available to the authors, however, based on the literature it is expected that the expression of TGF-β1, PD-L1 and VEGF is significantly higher in RCC tumors of high grades/stages than tumors with low grades/stages [32–35]. This evidence concerns the gene CD274 and renal cell carcinoma.